PDCD1LG2 and neoplasm: It was shown that IFNγ promotes the expression of PDL1 and PDL2, both on tumor cells and on immune infiltrating cells, and suppresses the effector function of tumor-specific T cells or NK cells through interaction with the immune inhibitory receptor PD1 [44,45].